Statistical analysis of clinical data between the low- and high-level groups of lung cancer patients revealed that the serum levels of CRP-SAA were closely associated with sex, smoking status, tumor size, lymph node involvement, distant metastasis, and clinical stage (Table 3). The gene discussed is SAA1; the disease is lung carcinoma.